Your browser doesn't support javascript.
loading
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study.
van de Donk, Niels W C J; Minnema, Monique C; van der Holt, Bronno; Schjesvold, Fredrik; Wu, Ka Lung; Broijl, Annemiek; Roeloffzen, Wilfried W H; Gadisseur, Alain; Pietrantuono, Giuseppe; Pour, Ludek; van der Velden, Vincent H J; Lund, Thomas; Offidani, Massimo; Grasso, Mariella; Giaccone, Luisa; Razawy, Wida; Tacchetti, Paola; Mancuso, Katia; Silkjaer, Trine; Caers, Jo; Zweegman, Sonja; Hájek, Roman; Benjamin, Reuben; Vangsted, Annette Juul; Boccadoro, Mario; Gay, Francesca; Sonneveld, Pieter; Musto, Pellegrino.
Afiliação
  • van de Donk NWCJ; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. Electronic address: n.vandedonk@amsterdamumc.nl.
  • Minnema MC; University Medical Center Utrecht, Department of Hematology, Utrecht University, Utrecht, Netherlands.
  • van der Holt B; HOVON Foundation, Rotterdam, Netherlands; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway.
  • Wu KL; Department of Hematology, ZNA Stuivenberg, Antwerp, Belgium.
  • Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Roeloffzen WWH; Department of Hematology, University Medical Center Groningen, University Groningen, Groningen, Netherlands.
  • Gadisseur A; Department of Haematology, Antwerp University Hospital, Edegem, Belgium.
  • Pietrantuono G; Unit of Hematology, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Lund T; Odense Hospital, Odense, Denmark.
  • Offidani M; AOU Ospedali Riuniti di Ancona, Ancona, Italy.
  • Grasso M; Azienda Ospedaliera S Croce e Carle, Cuneo, Italy.
  • Giaccone L; Department of Oncology and Hematology, SSD Stem Cell Transplant Center, AOU Citta della Salute e della Scienza di Torino, Torino, Italy.
  • Razawy W; HOVON Foundation, Rotterdam, Netherlands.
  • Tacchetti P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematolgia Seràgnoli, Bologna, Italy.
  • Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematolgia Seràgnoli, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
  • Silkjaer T; Aarhus University Hospital, Aarhus, Denmark.
  • Caers J; Department of Hematology, CHU Liege, Liege, Belgium.
  • Zweegman S; Department of Hematology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Benjamin R; King's College Hospital, London, UK.
  • Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Boccadoro M; European Myeloma Network, Torino, Italy.
  • Gay F; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Musto P; Department of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, and Hematology and Stem Cell Transplantation Unit, AOU Consorziale Policlinico, Bari, Italy.
Lancet Oncol ; 24(10): 1119-1133, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37717583
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article